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A tetracycline-regulated system was used to generate cell lines allowing tightly controlled expression of a hepatitis C
virus (HCV) cDNA comprising the 5* noncoding, the core, and part of the E1 regions. Production of 21-kDa processed
nucleocapsid protein could be regulated over a broad range by the concentration of tetracycline present in the culture
medium. Induction ratios of over 1000-fold were found using an HCV core–luciferase fusion construct. Core protein had
an intracellular half-life of 9 hr and corresponded to the product of 173 amino-terminal amino acids of the HCV open reading
frame. Sequential immunofluorescence microscopy revealed the presence of core antigen first in a predominantly perinuclear
fine-reticular staining pattern and subsequently also in cytoplasmic granules and vesicles. By immunoelectron microscopy
core protein was found on the endoplasmic reticulum membrane and on the surface of cytoplasmic lipid droplets. Growth
rate analyses and colony formation efficiency assays showed no major cytotoxic effect of HCV core protein expression per
se. HCV gene expression could be inhibited by an antisense oligonucleotide targeting a region immediately downstream of
the translation initiation codon. These cell lines represent important tools to investigate structural and functional properties
of HCV core protein and may be useful to evaluate gene therapeutic strategies against HCV in a cellular system. q 1996
Academic Press, Inc.
INTRODUCTION polyprotein precursor is co- and posttranslationally pro-
cessed by cellular and viral proteases to yield the mature
HCV4 is the most common etiologic agent of posttrans-
structural and nonstructural proteins (Grakoui et al., 1993;
fusion and sporadic non-A, non-B hepatitis (Choo et al.,
Selby et al., 1993).
1989; Kuo et al., 1989). The majority of acutely infected The first protein encoded by the HCV ORF is the puta-
individuals subsequently develop chronic infection, and tive nucleocapsid protein. This protein is composed of a
liver cirrhosis as well as hepatocellular carcinoma are basic, RNA-binding amino-terminal domain and a highly
well-recognized late complications of chronic hepatitis C hydrophobic carboxy-terminal region (Santolini et al.,
(Kiyosawa et al., 1990). HCV contains a single-stranded, 1994). Mature 21-kDa core protein is released from the
positive-sense RNA genome of approximately 9500 nu- polyprotein precursor by cellular signal peptidase and
cleotides (nt). As in flavi- and pestiviruses, the viral ge- may be associated with the endoplasmic reticulum (ER)
nome is composed of a 5* noncoding region (NCR), a membrane (Hijikata et al., 1991; Santolini et al., 1994).
long open reading frame (ORF) encoding a polyprotein Because the amino terminus of the envelope glycopro-
precursor of 3010 to 3033 amino acids (aa), and a 3* tein E1 was mapped to aa residue 192 (Hijikata et al.,
NCR (Choo et al., 1991; Takamizawa et al., 1991). The 1991), it was believed that processed core protein may
be composed of the first 191 aa of the HCV ORF. How-
ever, evidence for a second carboxy-terminal cleavage1 Present address: Department of Medicine II, University Hospital
Freiburg, D-79106 Freiburg, Germany. event occurring around aa position 173 was recently pre-
2 Present address: Department of Microbiology, The Tokyo Metropol- sented (Santolini et al., 1994). Subcellular localization
itan Institute of Medical Science, Bunkyo-ku, Tokyo 113, Japan. studies have relied on transient expression systems in3 To whom correspondence and reprint requests should be ad-
which core protein is strongly overexpressed (Harada etdressed at Molecular Hepatology Laboratory, MGH Cancer Center, 149
al., 1991; Selby et al., 1993; Santolini et al., 1994). In these13th Street, Charlestown, MA 02129. Fax: (617) 726-5609.
4 Abbreviations used: aa, amino acid; BSA, bovine serum albumin; studies, core protein was found mostly in a granular cyto-
ER, endoplasmic reticulum; HCV, hepatitis C virus; mAb, monoclonal plasmic staining pattern. However, it is presently un-
antibody; NCR, noncoding region; nt, nucleotide; ODN, oligodeoxy- known at what levels core protein is produced in the
nucleotide; ORF, open reading frame; PBS, phosphate-buffered saline;
hepatocyte during natural infection. Other investigatorsRLU, relative light units; SDS – PAGE, sodium dodecyl sulfate–poly-
have found core protein to be present also in the nucleusacrylamide gel electrophoresis; tTA, tetracycline-controlled transactiva-
tor; WT1, Wilms tumor suppressor gene 1 product. of transfected cells (Shih et al., 1993). In keeping with
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these observations, it has recently been suggested that cell types in the presence of low concentrations of tetra-
cycline, which prevents tTA from binding to tet operatorthe viral nucleocapsid protein may suppress hepatitis B
virus replication in a phosphorylation-dependent manner sequences. However, following withdrawal of tetracy-
cline from the culture medium, induction of expression(Shih et al., 1993; 1995) and that it may act in trans to
suppress a variety of viral and cellular promoters (Kim of a luciferase reporter gene over several orders of mag-
nitude has been reported (Gossen and Bujard, 1992).et al., 1994). This raises the interesting possibility that
HCV core as a structural protein may have certain func- In contrast to inducible systems based on eukaryotic
promoters responsive to heavy metal ions or steroid hor-tional properties and may affect cellular gene expression,
proliferation, and viability. mones, for example, the tetracycline-regulated system is
particularly attractive because it allows tight control ofThe lack of a suitable cell culture system permissive
for HCV infection and replication has hampered not only gene expression without leakiness of the noninduced
state and does not suffer from pleiotropic effects causedthe investigation of the HCV life cycle but also the evalua-
tion of antiviral agents and gene therapeutic strategies by the inducing principles themselves (Gossen et al.,
1993).aimed at inhibiting HCV replication and gene expression.
Infection of primary hepatocytes (Lanford et al., 1994) Here, we present the detailed characterization of
a cell line termed UTH-28 allowing tightly regulatedand established cell lines (Shimizu et al., 1992) in vitro
and transfection of a full-length viral RNA into HuH-7 expression of HCV core protein. This cell line was used
to study the half-life and processing as well as thecells (Yoo et al., 1995) generally yielded low levels of
presumable replicative intermediates detectable only by subcellular localization and fine morphology of the nu-
cleocapsid protein. Moreover, the influence of HCVpolymerase chain reaction.
The aim of this study was to establish cell lines core protein expression on cellular proliferation and
viability was examined by growth rate analyses andallowing tightly regulated expression of HCV core protein
in order to study structural and functional properties of colony formation efficiency assays. Finally, data are
presented to indicate that these inducible cell linesthe viral nucleocapsid protein. More specifically, we
were interested in analyzing the subcellular localization may represent valuable cellular systems to evaluate
gene therapeutic strategies against HCV.and morphology of core protein at different expression
levels. In addition, a possible cytotoxic effect of HCV core
protein was investigated because repeated attempts to MATERIALS AND METHODS
raise constitutively core-expressing cell lines using cyto-
Plasmid constructs
megalovirus promoter-driven expression constructs in a
variety of mammalian cell lines have previously been A cloned genotype 1b HCV cDNA comprising nt 1 to
1321 (Wakita and Wands, 1994) was inserted into theunsuccessful. Finally, we wanted to establish a cellular
model system which would allow the evaluation of gene EcoRI–XbaI sites of pUHD10-3 (Gossen and Bujard,
1992) using standard cloning procedures (Sambrook ettherapeutic approaches against HCV. In this regard, criti-
cal target regions in the HCV 5* noncoding and core al., 1989) to yield plasmid pUHDTH. This construct allows
expression of the HCV cDNA fragment under control ofcoding regions have previously been identified which are
highly susceptible to inhibition of gene expression by a tTA-dependent promoter. In addition, a chimeric con-
struct was generated in which the 5* NCR and the se-antisense oligodeoxynucleotides (ODN; Wakita and
Wands, 1994) and antisense RNA (T.W. et al., manuscript quence coding for the amino-terminal 82 aa of the HCV
core protein were fused in frame to the firefly luciferasein preparation) as assessed in an in vitro translation
assay. gene (Fig. 1A). The luciferase coding region without the
translation initiation codon was recovered from plasmidThus, a recently described gene expression system
was employed that is based on regulatory elements of pSP-luc/ (Promega, Madison, WI) by polymerase chain
reaction using sense primer 5* GCG GGT ACC CTG AAGthe tetracycline-resistance operon of Escherichia coli
(Gossen and Bujard, 1992) to establish cell lines which ACG CCA AAA ACA TAA AG 3 * (KpnI site underlined)
and reverse primer 5* AGA TCG ATG ATA TCG AATinducibly express a subgenomic HCV cDNA fragment
spanning nt 1 to 1321. This system consists of a tetracy- TCT CTA GAA TTA CA 3 * (XbaI site underlined). The
amplification product was digested with KpnI and XbaIcline-controlled transactivator, termed tTA, which is com-
posed of the tet repressor fused to the activating domain and ligated together with a BamHI–KpnI HCV cDNA frag-
ment comprising nt 1 to 584 into the BamHI–XbaI sitesof VP16 of herpex simplex virus, and of a tTA-dependent
promoter, which is composed of a minimal sequence of pcDNA3 (Invitrogen, San Diego, CA) to yield plasmid
pCMVTHluc/. This construct encodes a 70-kDa fusionderived from the cytomegalovirus intermediate early pro-
moter combined with heptameric tet operator sequences. protein that can be detected by Western blot analysis
and immunofluorescence microscopy using monoclonalWhen integrated into the proper genomic environment,
the tTA-dependent promoter is virtually silent in many antibody (mAb) C7-50, which recognizes a linear epitope
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FIG. 1. Characterization of UTHL cell lines. (A) Schematic representation of the expression cassettes present in UTH and UTHL cell lines. A
hydrophilicity plot of the amino acid sequence deduced from the cDNA used in this study is depicted at the top. Hydrophilic domains are shown
above the midline. The epitope recognized by mAb C7-50 is indicated by a black box. (B and C) HuH-7 cells were transiently transfected with
pcDNAHXTH (full-length HCV core protein; B) or with pCMVTHluc/ (C) and examined 48 hr posttransfection by immunofluorescence microscopy
using mAb C7-50 as described under Materials and Methods. (D) Immunofluorescence staining using mAb C7-50 of pooled UTHL clones cultured
for 24 hr in the absence of tetracycline. (E) Lysates of UTHL-16.1 cells cultured for 24 hr in the presence (/) or in the absence (0tet) of tetracycline
were separated by 12% SDS–PAGE and analyzed by immunoblotting using mAb C7-50. Molecular weight standards in kDa are shown on the left.
(F) Tetracycline was withdrawn from UTHL-16.1 cells at time point 0 and RLU/50,000 cells were subsequently determined every hour up to 6 hr.
(G) UTHL-16.1 were cultured for 24 hr in the presence or in the absence of tetracycline and RLU/50,000 cells were determined as described under
Material and Methods.
located within aa residues 21 to 40 of the HCV core 5* end, the BamHI–XbaI fragment of pCMVTHluc/ was
inserted into the BamHI–XbaI sites of pGEM11-Zf(/)protein (Moradpour et al., 1996). Alternatively, expression
of the chimeric protein can be quantitatively assessed (Promega) and recovered as an EcoRI–XbaI fragment.
This fragment was introduced into the EcoRI–XbaI sitesby luciferase assay. To introduce an EcoRI site at the
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of pUHD10-3 to yield plasmid pUHDTHluc/. Plasmid units (RLU) were measured in a LKB-Wallac 1251 Lumi-
nometer (Wallac, Turku, Finland).constructs encoding the first 154 (pcDNAHX2C154), 173
(pcDNAHX2C173), 191 (pcDNA5-9-1), and 326 (pcDNAHXTH)
Northern blottingaa residues of the HCV ORF under control of the cyto-
megalovirus intermediate early promoter and enhancer
Total cellular RNA was extracted with RNAzol (Biotecx
in pcDNA3 were derived from the 1321-bp HCV cDNA
Laboratories, Houston, TX). The 1321-bp HCV cDNA frag-
by polymerase chain reaction.
ment used as a probe was 32P-labeled to a specific activ-
ity of 3 to 5 1 108 cpm/mg by multiprime labeling (Amer-Cell lines
sham, Arlington Heights, IL). Denaturing agarose gel
U-2 OS human osteosarcoma cells were obtained from
electrophoresis and Northern blotting were performed
the American Type Culture Collection (Rockville, MD) and
according to standard protocols (Sambrook et al., 1989).
maintained in Dulbecco’s modified Eagle medium sup-
plemented with 10% heat-inactivated fetal bovine serum, Western blot analysis
2 mM glutamine, 50 units/ml penicillin G, and 50 mg/ml
Cells were lysed in a buffer containing 150 mM NaCl,streptomycin at 377C in a humidified atmosphere of 7%
1% NP-40, 0.5% deoxycholate, 0.1% sodium dodecyl sul-CO2 . HuH-7 is a relatively well-differentiated human he-
fate (SDS), 50 mM TrisrCl, pH 8.0, 1 mM phenylmethyl-patocellular carcinoma cell line (Nakabayashi et al.,
sulfonyl fluoride, 1 mg/ml aprotinin, 1 mg/ml leupeptin,1982). Transfections were performed using a modified
and 1 mg/ml pepstatin A. Immunoblotting was performedcalcium phosphate precipitation method (Chen and
after SDS–polyacrylamide gel electrophoresis (SDS–Okayama, 1987). The establishment of the constitutively
PAGE) according to a standard protocol (Sambrook ettTA-expressing founder cell line UTA-6 was reported pre-
al., 1989). Briefly, proteins were electrotransferred ontoviously (Englert et al., 1995). Briefly, U-2 OS cells were
Immobilon-P membranes (Millipore, Bedford, MA) andcotransfected with pUHD15-1 (Gossen and Bujard, 1992)
membranes were blocked with phosphate-buffered sa-and pCMV-Neo-Bam (Baker et al., 1990), followed by se-
line (PBS) containing 3% nonfat dry milk and 3% bovinelection in medium containing 400 mg/ml G418 (Gibco
serum albumin (BSA) for 2 hr at 207C. Blots were subse-BRL, Grand Island, NY). G418-resistant clones were
quently incubated for 1 hr with 1 mg/ml purified mAb C7-screened for tight control of gene expression by transient
50. Washing steps were performed with PBS containingtransfection of the reporter construct pUHC13-3 which
0.1% Tween 20. Horseradish peroxidase-labeled sheepcontains the firefly luciferase gene under control of a
anti-mouse Ig was used at a dilution of 1:5000 for detec-tTA-dependent promoter (Gossen and Bujard, 1992). In
tion of bound primary antibody by enhanced chemilumi-a second step, UTA-6 cells were cotransfected with
nescence (Amersham). The rabbit polyclonal antibodypUHDTH and pBabepuro (Morgenstern and Land, 1990),
WTc8 directed against WT1 (Englert et al., 1995) wasfollowed by selection in culture medium containing 400
used in control experiments. Densitometry scanning wasmg/ml G418 and 1 mg/ml puromycin (Sigma, St Louis,
performed using the Apple Scanner (Apple Computers,MO). Tetracycline was added at a concentration of 1 mg/
Cupertino, CA) and NIH Image 1.44 software.ml. G418- and puromycin-resistant clones, termed UTH,
were screened for expression of HCV core protein upon
In vitro transcription and translationwithdrawal of tetracycline by immunofluorescence mi-
croscopy using mAb C7-50. Positive clones were ex-
An HCV core cDNA (nt 342 to 914) coding for aa resi-
panded and rescreened by immunoblotting of cells
dues 1 to 191 was subcloned into the BamHI–EcoRI
grown in the presence and in the absence of tetracycline.
sites of pGEM-11Zf(/) and transcribed and translated in
Similarly, UTHL cell lines were established by transfec-
vitro using the TNT SP6 coupled rabbit reticulocyte lysate
tion of UTA-6 cells with pUHDTHluc/ and pBabepuro.
system (Promega).
G418- and puromycin-resistant clones were screened by
luciferase assay and expression of HCV core–luciferase Subcellular fractionation
fusion protein was confirmed by immunostaining and
-blotting using mAb C7-50. The control cell line UW14 Subcellular fractionation was performed according
to a standard protocol (Ausubel et al., 1989). Briefly, 7which inducibly expresses the WTAR mutant of the Wilms
tumor suppressor gene 1 product (WT1) in a UTA-6 cell 1 107 UTH-28 cells grown for 48 hr in the absence of
tetracycline were homogenized in a hypotonic bufferbackground was described previously (Englert et al.,
1995). containing 10 mM TrisrCl, pH 7.5, and 2 mM MgCl2 ,
followed by centrifugation at 1000 g for 5 min to yield
Luciferase assays a nuclear pellet. The supernatant fraction was adjusted
to 0.25 M sucrose and the mitochondrial pellet wasLuciferase assays were performed according to a
standard protocol (Ausubel et al., 1989). Relative light obtained by centrifugation at 9000 g for 10 min. Finally,
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the microsomal pellet (P-100) was separated from the 50% methanol and 10% glacial acetic acid as described
previously (Frebourg et al., 1992).cytosolic supernatant (S-100) by centrifugation at
105,000 g for 20 min.
Antisense ODN inhibition experiments
Immunofluorescence microscopy
Phosphodiester ODN and phosphorothioate-modified
ODN were purchased from QCB, Inc. (Hopkinton, MA). AIndirect immunofluorescence microscopy was per-
17-mer antisense ODN termed A367-17 (or A367-17S informed essentially as described (Moradpour et al., 1996).
the case of the corresponding phosphorothioate ODN)In brief, cells grown as monolayers on microscope cover
complementary to nt 367 to 351 (sequence 5* CTT TGAslides were fixed with 2% paraformaldehyde, permeabil-
GGT TTA GGA TT 3*; Wakita and Wands, 1994) was usedized with 0.05% saponin, and incubated for 1 hr with 1
in this study. Sense ODN S351-17 and S351-17S weremg mAb C7-50 in 100 ml PBS containing 3% BSA and
used as controls. UTH-28 cells, and UW14 cells as0.05% saponin. Bound mAb was revealed with a fluores-
controls, were grown to 80 to 90% confluence in six-cein isothiocyanate-conjugated goat F(ab* )2 fragment to
well tissue culture plates. Subsequently, cells were trans-mouse IgG F(ab* )2 (Cappel, Durham, NC). Cover slides
fected with 4 mg ODN per well (0.275 mM ) by the calciumwere mounted in SlowFade (Molecular Probes, Eugene,
phosphate precipitation method and additional free ODNOR) and examined with a Nikon Labophot photomicro-
were added to the culture medium at a concentration ofscope equipped with the epifluorescence attachment
2 mM. Using fluorescent ODN we had found that ODNEF-D (Nikon, Garden City, NY).
were efficiently delivered to approximately 80% of UTH-
28 cells by calcium phosphate precipitation (data notImmunoelectron microscopy
shown). Four hours later, cells were derepressed by with-
UTH-28 cells grown for 48 hr in the presence or in the drawal of tetracycline from the culture medium and ODN
absence of tetracycline were fixed with paraformalde- were reapplied at the same concentrations. Cells were
hyde lysine periodate fixative (McLean and Nakane, harvested 6 hr later and processed for Western blot anal-
1974) containing 5% sucrose, permeabilized with 0.05% ysis as described above.
saponin, and incubated for 16 hr at 47C with 10 mg/ml
mAb C7-50 in PBS containing 3% BSA and 0.05% saponin. RESULTS
Subsequently, cells were washed and incubated for 1 hr
with biotinylated anti-mouse IgG. Cells were washed and Establishment of tetracycline-regulated cell lines
incubated with ABC reagent (Vector Laboratories, Burlin-
To quantitatively examine the induction capacity ofgame, CA), washed again, and finally incubated in 0.05%
UTA-6 founder cells in the context of constructs con-diaminobenzidine and 0.02% H2O2 in 50 mM TrisrCl, pH
taining the HCV 5* NCR, we first generated cell lines,7.4, to reveal sites of peroxidase activity. Subsequently,
termed UTHL, which inducibly express a fusion proteincells were incubated in osmium tetroxide, dehydrated in
comprising the first 82 aa residues of HCV core fused tograded ethanols, removed from the tissue culture plates
firefly luciferase (Fig. 1A). Interestingly, by immunofluo-with propyleneoxide, and embedded in LX-112 resin
rescence microscopy we found that, in contrast to full-(Ladd Industries, Burlington, VT). Finally, thin sections
length HCV core protein (Fig. 1B), carboxy-terminally trun-were examined, with or without heavy metal counter-
cated nucleocapsid in the context of the HCV core–lucif-staining, with a Philips CM10 electron microscope.
erase fusion protein was localized in the nucleus with
accumulation in nucleoli of transiently transfected HuH-Growth curves and colony formation efficiency
7 cells (Fig. 1C) and stably transfected UTHL cells (Fig.assays
1D). Of 60 screened UTHL clones 31 displayed luciferase
activity upon withdrawal of tetracycline. Of 25 clonesTo generate growth curves, 2 1 104 UTH-28 cells per
well were seeded into six-well tissue culture plates in tested in the presence and in the absence of tetracycline,
12 showed induction ratios greater than 2, and 8 greatermedium containing tetracycline. Tetracycline was with-
drawn 16 hr later from half of the wells and cells from than 10. A clone termed UTHL-16.1 was characterized in
detail. Figure 1E demonstrates that the 70-kDa HCVtriplicate wells were harvested and counted daily thereaf-
ter for 12 days. For colony formation efficiency assays, core–luciferase fusion protein can be detected by immu-
noblotting using mAb C7-50 only in UTHL-16.1 cells cul-1000 UTH-28 cells were seeded into 100-mm tissue cul-
ture dishes in the presence of tetracycline. Tetracycline tured in the absence of tetracycline. In this cell line, gene
expression could be detected 3 hr after withdrawal ofwas withdrawn from half of the dishes 16 hr later and
cells were cultured in the presence or in the absence of tetracycline and luciferase activity rapidly increased
thereafter, as shown in Fig. 1F. After 24 hr, 472 { 52tetracycline for 7 days. To visualize colonies, culture
dishes were stained with 0.25% brilliant blue R-250 in RLU/50,000 cells were found in cells cultured in the pres-
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in the presence of 1 mg/ml tetracycline. However, the
specific transcript of approximately 1600 nt was readily
detectable after withdrawal of tetracycline. In the ab-
sence of tetracycline an additional minor transcript of
approximately 3600 nt, probably corresponding to a read-
through transcript, could be detected after long exposure
of Northern blots. The immunoblot shown in Fig. 2B illus-
trates a time course of HCV core protein expression in
UTH-28 cells. No core protein was observed in the pres-
ence of tetracycline. However, withdrawal of tetracycline
led to the production of 21-kDa core protein which be-
came detectable after 6 hr and peaked at 48 hr. When
tetracycline was readded to the culture medium, core
protein levels decreased and the protein disappeared
from the cells within another 48 hr. Importantly, produc-
tion of HCV core protein could not only be turned on and
off, but the level of protein expression could be quantita-
tively regulated over a broad range by the concentration
of tetracycline present in the culture medium, as shown
in Fig. 2C. Core protein production was completely re-FIG. 2. Tight control of gene expression in UTH-28 cells. (A) 20 mg
total cellular RNA of UTH-28 cells cultured for 24 hr in the presence pressed at a tetracycline concentration of 1 to 0.1 mg/ml
(/) or in the absence (0tet) of tetracycline was analyzed by Northern and became detectable by immunoblotting at a concen-
blotting as described under Materials and Methods. The ethidium bro- tration of 0.025 mg/ml. Gene expression was most dy-
mide-stained gel demonstrating 28 S and 18 S RNA is shown below. (B)
namically regulated between 0.025 and 0.001 mg/ml andWestern blot time course. UTH-28 cells were cultured in the presence of
was maximal in the absence of tetracycline.tetracycline until time point 0, when tetracycline was withdrawn from
the medium. Subsequently, cells were harvested at regular time inter-
vals up to 48 hr, when tetracycline was readded to the medium. 90 mg Determination of HCV core protein half-life
protein was separated by 15% SDS–PAGE and analyzed by immunoblot
using mAb C7-50. Molecular weight standards in kDa are shown on
The availability of tightly regulated cell lines allowedthe left. (C) Regulation of HCV core protein expression by the concentra-
us to determine the intracellular half-life of HCV coretion of tetracycline present in the culture medium. UTH-28 cells were
cultured for 24 hr in medium containing various concentrations of tetra- protein. For this purpose, UTH-28 cells were derepressed
cycline. 40 mg protein was separated by 15% SDS–PAGE and analyzed for 48 hr to allow full induction of HCV core protein pro-
by Western blot using mAb C7-50. duction. Subsequently, tetracycline was added to the cul-
ture medium and cells were harvested at regular time
intervals for Northern and Western blot analyses. Theence and 521,700 { 158,531 RLU/50,000 cells in cells
signal intensity was quantitatively assessed by densi-cultured in the absence of tetracycline, corresponding to
tometry scanning and arbitrary density units were plottedan induction ratio of 1091 { 337 (Fig. 1G).
against time. Using the regression equations shown inScreening of 36 UTH clones revealed 11 positive
Fig. 3, a half-life of 0.9 hr was calculated for the transcriptclones of which 7 allowed inducible expression of HCV
and a half-life of 9 hr was found for core protein.core protein, as assessed by Western blot analysis of
cells cultured in the presence and in the absence of
Processing of HCV core protein in UTH-28 cellstetracycline. A clone termed UTH-28 was characterized
in detail, but most results were confirmed in three other
Processed core protein expressed in UTH-28 cells wasindependent clones (UTH-3, -16, and -35). UTH-28 cells
compared by Western blot analysis to the products en-have been maintained in culture for over 16 months and
coded by carboxy-terminally truncated core expressionmore than 70 passages without loss of tightly regulated
constructs. As shown in Fig. 4, HCV core protein pro-gene expression. Moreover, all subclones derived from
duced in UTH-28 cells comigrated with the products ofthis cell line continued to express HCV core protein with
constructs coding for the first 173, 191, and 326 aa resi-the same characteristics.
dues of the HCV ORF. However, the product of the first
154 aa migrated faster and in vitro-transcribed andTightly regulated expression of HCV core protein in
-translated 191-aa HCV core protein migrated slower.UTH-28 cells
These results indicate that HCV core protein processed
in UTH-28 cells corresponds to the product of approxi-As shown in Fig. 2A, no HCV cDNA transcript was
found by Northern blot analysis in UTH-28 cells cultured mately 173 amino-terminal aa of the HCV ORF.
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FIG. 5. Subcellular fractionation. UTH-28 cells were cultured in the
absence of tetracycline for 48 hr. Subcellular fractionation was per-
formed as described under Materials and Methods. 40 mg protein from
each fraction was separated by 15% SDS–PAGE followed by immu-
noblotting using mAb C7-50.
lular fractionation revealed the presence of HCV core
protein in membrane-containing fractions, but not in theFIG. 3. Half-life of HCV core protein in UTH-28 cells. UTH-28 cells
were cultured for 48 hr in the absence of tetracycline. Tetracycline soluble cytoplasmic fraction (Fig. 5). The presence of
was then added to the culture medium and cells were harvested and core protein in the nuclear fraction probably represents
processed for Northern and Western blot analysis at regular time inter- protein in copelleted perinuclear membranes since no
vals. 20 mg total cellular RNA was used for Northern blotting. 30 mg
core protein could be detected in the nucleus of UTH-28protein was separated by 15% SDS–PAGE and immunoblotted with
cells by immunostaining.mAb C7-50, as shown in the inset. The intensity of Northern (triangles)
and Western (circles) blot signals was quantified by densitometry scan- Immunofluorescence microscopy studies using mAb
ning and arbitrary density values were plotted in a semilogarithmic C7-50 are shown in Fig. 6. No immunoreactivity was
fashion against time. The equations shown at the top were derived found when cells were cultured in the presence of tetra-
from an exponential curve fit generated by the Cricket Graph III program
cycline (Fig. 6A). However, as shown in Fig. 6B, core(Computer Associates International, Inc., Islandia, NY) and used for
protein became detectable 6 hr following derepressionhalf-life determination.
first in a fine-reticular perinuclear staining pattern. In ad-
dition, superimposed granules disseminated throughout
Subcellular localization of HCV core protein the cytoplasm and conspicuous vesicular structures
which varied in number and size became detectableThe subcellular localization of HCV core protein was
upon continued derepression (Figs. 6C–6F). An essen-examined by subcellular fractionation, immunofluores-
tially unchanged staining pattern was observed for up tocent staining, and immunoelectron microscopy. Subcel-
10 days after derepression (data not illustrated). As found
also by others (Precious et al., 1995), there was some
degree of heterogeneity in expression levels between
individual cells, even if all subclones derived from UTH-
28 cells continued to produce HCV core protein with
identical characteristics. In contrast to the results ob-
tained with carboxy-terminally truncated core protein
(Figs. 1C and 1D), no nuclear staining was observed in
the case of full-length HCV core protein.
Immunoelectron microscopy revealed the presence of
HCV core protein on ER membranes and on the surface
of cytoplasmic lipid droplets, as shown in Fig. 7. Positive
staining was found on the ER membrane, often on rough
ER surrounding mitochondria, but not inside the ER cis-
ternae. The specificity of the staining reaction was con-
firmed by negative results obtained in cells grown in the
presence of tetracycline (data not illustrated).FIG. 4. Processing of HCV core protein in UTH-28 cells. Cell lysates
were examined by immunoblot using mAb C7-50 after 15% SDS–PAGE.
Lanes 1 and 2, UTH-28 cells grown for 24 hr in the absence and Growth curves and colony formation efficiency
in the presence of tetracycline, respectively. Lanes 3 to 6, HuH-7
assayscells transiently transfected with HCV core expression constructs
pcDNAHX2C154 (lane 3), pcDNAHX2C173 (lane 4), pcDNA591 (lane 5),
To investigate the effect of HCV core protein expres-and pcDNAHXTH (lane 6). Lane 7 represents in vitro-transcribed and
sion on cellular proliferation and viability, UTH-28 cells-translated 191-aa HCV core protein. Molecular weight standards in
kDa are shown on the left. were cultured in the presence or in the absence of
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FIG. 6. Immunofluorescence staining. UTH-28 cells were cultured (A) in the presence of tetracycline or for (B) 6, (C) 12, (D and E) 24, and (F) 48
hr in the absence of tetracycline and examined by immunofluorescence microscopy using mAb C7-50 as described under Materials and Methods.
The arrows in E and F indicate vesicular structures.
tetracycline and the number of cells was determined the presence or the absence of tetracycline (Fig. 8B).
Consistent with the difference observed in the meanby counting daily. As shown in Fig. 8A, expression of
core protein led to an increase in the mean doubling doubling time, the diameter of colonies grown in the
absence of tetracycline was smaller than that of colo-time from 22.8 to 25.9 hr. However, the same saturation
density was reached under both conditions. In addi- nies grown in the presence of tetracycline. These re-
sults indicate that core protein expression per se didtion, colony formation efficiency assays indicated that
roughly the same number of colonies formed in either not have a major cytotoxic effect in UTH-28 cells. Anal-
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FIG. 7. Immunoelectron microscopy. UTH-28 cells were cultured in the absence of tetracycline for 48 hr and processed for immunoelectron
microscopy using mAb C7-50 as described under Materials and Methods. (A) Staining of ER membranes (arrows). Original magnification 24,0001.
Calibration bar represents 1 mm. (B) Staining of cytoplasmic lipid droplets (arrows). Original magnification 10,5001. Calibration bar represents
1 mm.
ogous results were found in three independent UTH SEM of three experiments normalized to untreated dere-
pressed cells were 27.7 { 5.8% with A367-17S and 85.7 {clones (data not illustrated).
18.6% with ODN S351-17S. As one would expect, unmodi-
fied phosphodiester ODN had no significant inhibitory effectAntisense ODN inhibition experiments
in this cell culture system. As additional controls for specific-
To assess the inhibitory effect of antisense ODN on HCV ity we performed the inhibition experiments in parallel in
gene expression in a cellular context, UTH-28 cells were UW14 cells which inducibly express the WTAR mutant of
treated with various ODN during a 6-hr derepression period WT1. As shown in Fig. 9, both phosphorothioate-modified
and the amount of core protein produced was measured antisense and control ODN led to a nonspecific inhibition
by immunoblotting and densitometry scanning. As shown in of WTAR expression to 74 and 69%, respectively, compared
Fig. 9, treatment of UTH-28 cells with the phosphorothioate- to untreated derepressed cells.
modified antisense ODN A367-17S markedly inhibited HCV
DISCUSSIONgene expression. The control ODN S351-17S, however, only
slightly inhibited core protein production compared to un- HCV core inducible cell lines were derived from U-2
OS cells by stable transfection with the chimeric trans-treated cells. Mean core protein signal density values {
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expressing an HCV core–luciferase fusion construct (Fig.
1). The induction ratio for full-length HCV core-expressing
UTH-28 cells could not be quantitatively determined be-
cause in the repressed state core protein was never
detectable by Northern or Western blot analyses.
In the experiment shown in Fig. 3, we used the UTH-
28 cell line to determine the intracellular half-life of HCV
core protein. In contrast to cycloheximide inhibition ex-
periments, the tetracycline-regulated system enabled us
to perform these studies without affecting the overall
metabolism of the cell. We found that the HCV cDNA
transcript disappeared from the cells with a half-life of
0.9 hr after addition of tetracycline to the culture medium
and that it was no longer detectable after 6 hr. This
indicates a rapid uptake of tetracycline by UTH-28 cells,
followed by a fast and efficient shutdown of transcription.
A half-life of 9 hr was found for HCV core protein. This
half-life may not be directly correlated to the protein turn-
over during natural infection in the hepatocyte because
the protein may accumulate in unphysiological cellular
compartments as a result of overexpression in cell cul-
ture. On the other hand, viral or cellular factors may inter-
act with and stabilize core protein during formation of
viral particles in naturally infected cells. It is important
to note, however, that this relatively long half-life would
render the evaluation of antisense inhibition strategies
at the protein level in constitutively expressing cell lines
FIG. 8. Influence of core protein production on cellular proliferation difficult because such cells would have to be treated for
and viability. (A) Growth curve analysis. UTH-28 cells were grown in
extended time periods in order to assess inhibitory ef-the presence (empty circles) and in the absence (filled circles) of tetra-
fects, particularly if they are incomplete.cycline and counted daily as described under Materials and Methods.
The top inset represents growth curves plotted in a semilogarithmic With regard to processing of the HCV core protein, the
fashion with the resulting regression equations. A mean doubling time results presented in Fig. 4 indicate that in addition to
of 22.9 hr was calculated for cells growing in the presence and of 25.9 cleavage of E1 from the polypeptide precursor between
hr for cells growing in the absence of tetracycline. The bottom inset
aa 191 and 192 (Hijikata et al., 1991), a second cleavageshows an immunoblot of cells grown in the presence and in the ab-
event occurs around aa position 173 to generate thesence of tetracycline harvested at Day 4, 8, and 12 and demonstrates
that core protein production was tightly regulated throughout the exper- carboxy terminus of the mature core protein. This is in
iment. (B) Colony formation efficiency assays. 1000 UTH-28 cells were accordance with the findings of Santolini et al. (1994) in
seeded into 100-mm tissue culture dishes and cultured for 7 days in
the presence or in the absence of tetracycline. Subsequently, colonies
were visualized as described under Materials and Methods.
activator tTA and with a cDNA comprising the HCV 5*
NCR, the core, and part of the E1 region under the tran-
scriptional control of a tTA-dependent promoter. In these
cells, expression of HCV core protein could be tightly
regulated by the concentration of tetracycline present in
FIG. 9. Antisense ODN inhibition experiments. UTH-28 cells (top)the culture medium, as shown by Northern and Western
and UW14 control cells (bottom) were treated with antisense ODN
blot analyses. Because position effects and differences A367-17 (lane 1) and A367-17S (lane 3) or sense control ODN S351-
in the copy number of integrated transcription units affect 17 (lane 2) and S351-17S (lane 4) as described under Materials and
Methods. Lane 5 represents cells grown for 6 hr in the absence ofthe basal level and inducibility of gene expression, indi-
tetracycline without any ODN treatment and lane 6 represents cellsvidual UTH and UTHL clones expressed HCV core and
which were kept repressed during the same time period. Cell lysatescore–luciferase fusion proteins with different induction
were analyzed by immunoblotting using mAb C7-50 to reveal HCV
ratios. It was therefore important to carefully select tightly core protein produced by UTH-28 cells and with the rabbit polyclonal
regulated and highly inducible clones. An induction ca- antibody WTc8 to reveal the WTAR mutant of WT1 produced by UW14
cells.pacity of over 1000-fold was found in UTHL-16.1 cells
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an in vitro translation system and in HeLa cells. These cles gave a ring-like fluorescence pattern and contained
an empty inner space, suggesting that core protein wasinvestigators suggested that the second cleavage at aa
position 173 was mediated by the ER signal peptidase associated with the vesicle surface.
In accordance with the results of subcellular fraction-as well. However, the mechanism of translocation and
cleavage at the amino terminus of the hydrophobic se- ation studies (Fig. 5), immunoelectron microscopy using
mAb C7-50 revealed the presence of HCV core proteinquence between aa 174 and 191 remains to be further
examined. In contrast to the findings of others (Selby et on ER membranes of UTH-28 cells cultured in the ab-
sence of tetracycline. Positive staining was found alongal., 1993; Lo et al., 1995), we did not detect shorter
(19-, 18-, or 16-kDa) core protein forms in our expression membranes but not inside ER cisternae, which is consis-
tent with a localization on the cytoplasmic side of the ERsystem.
When we examined UTHL cells by immunofluores- membrane predicted by biochemical analysis (Santolini
et al., 1994). Interestingly, core protein was also foundcence microscopy we found that carboxy-terminally trun-
cated core protein in the context of a luciferase fusion on the surface of cytoplasmic lipid droplets. Based on
their size, which varied among cells, and their intracellu-construct was translocated into the nucleus (Fig. 1). This
feature was found not only in U-2 OS-derived inducible lar distribution these positively stained lipid droplets
most probably correspond to the vesicular structures ob-cell lines but also in transiently transfected HuH-7 cells
and is consistent with potential nuclear localization sig- served by immunofluorescence microscopy. Data sug-
gesting an association of HCV core protein with lipidnals being present in the amino terminus of HCV core
protein (Chang et al., 1994; Ravaggi et al., 1994; Lo et droplets was very recently presented also by Barba et
al. (1995).al., 1995; Suzuki et al., 1995). In full-length core protein
the influence of these nuclear localization signals may Expression of HCV core protein in UTH-28 cells had
only a minor growth-inhibitory effect, as reflected by abe counterbalanced by the hydrophobic carboxy-terminal
region, which is probably responsible for the association slight prolongation of the mean doubling time of cells
cultured in the absence of tetracycline (Fig. 8). Thus, noof the protein with intracellular membranes. Remarkably,
the truncated protein appeared to accumulate in nucleoli, major cytotoxic effect of core protein expression per se
was observed in UTH cells.which is consistent with the predicted RNA-binding prop-
erties of the amino-terminal portion of HCV core protein The results presented in Fig. 9 indicate that the induc-
ible cell lines described here may provide a useful sys-(Santolini et al., 1994). When transiently transfected HuH-
7 cells were examined by immunofluorescence micros- tem to assess nucleic acid-based strategies such as
antisense ODN and antisense RNA aimed at inhibitingcopy, it was found that the 173-aa product encoded by
pcDNAHX2C173 was localized equally in the cytoplasm HCV gene expression within the cell. Such a model sys-
tem is of major interest since no practical and efficientand in the nucleus, whereas full-length constructs were
localized only in the cytoplasm and the 154-aa product cell culture system that supports HCV replication is pres-
ently available. In this regard, the fine sequence specific-of pcDNAHX2C154 mostly in the nucleus (data not illus-
trated). It is therefore possible that the association of ity testing at nt positions 351 to 377 previously allowed
the identification of a 17-mer antisense ODN termedmature core protein with intracellular membranes is con-
solidated during processing at the carboxy terminus of A367-17 which targets a highly conserved region immedi-
ately downstream of the translation initiation codon andthe protein. Alternatively, the actual second cleavage site
may differ by a few aa from position 173 and minor differ- which very efficiently inhibits HCV gene expression in
an in vitro translation assay (Wakita and Wands, 1994).ences in this region may ultimately determine the subcel-
lular localization of the protein. It is presently unknown, Interestingly, the region that is targeted by antisense
ODN A367-17 has recently been shown to be requiredhowever, if nuclear-localized forms of core protein arise
during natural infection in the hepatocyte. for efficient internal initiation of HCV RNA translation
(Reynolds et al., 1995). Here, we extended the studiesIn contrast to transient expression studies in a variety
of mammalian cell lines (Harada et al., 1991; Selby et al., on this ODN and found that phosphorothioate-modified
A367-17S was able to efficiently inhibit HCV core protein1993; Moradpour et al., 1996), the ability to observe the
production of HCV core protein in a sequential manner production in UTH-28 cells. Because unmodified phos-
phodiester ODN are rapidly degraded by nucleases pres-has allowed us to dissect the formation of staining pat-
terns over time. Six hours after withdrawal of tetracycline ent in the culture medium and in cells (Wagner, 1994),
we were able to find a reproducible antisense effectmost cells displayed a predominantly perinuclear fine-
reticular staining pattern suggestive of an ER localization in our cell culture system only using phosphorothioate-
modified, nuclease-resistant ODN. However, in our stud-of core protein. Subsequently, granules appeared in a
more dispersed pattern throughout the cytoplasm, and ies the phosphorothioate-modification of ODN had the
disadvantage of bringing about nonspecific inhibitory ef-vesicular structures of varying amount and size ap-
peared. By immunofluorescence microscopy, these vesi- fects and we found the window in which specific effects
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of the p53 tumor suppressor gene in patients with high risk for canceron HCV core protein expression could be observed to
inactivate the p53 protein. Proc. Natl. Acad. Sci. USA 89, 6413–6417.be rather narrow. This was also the case when phospho-
Gossen, M., and Bujard, H. (1992). Tight control of gene expression in
rothioate-modified ODN were used in the in vitro transla- mammalian cells by tetracycline-responsive promoters. Proc. Natl.
tion assay previously described (Wakita and Wands, Acad. Sci. USA 89, 5547–5551.
Gossen, M., Bonin, A. L., and Bujard, H. (1993). Control of gene activity1994; data not shown). However, the value of the cell
in higher eukaryotic cells by prokaryotic regulatory elements. Trendslines described here is to provide a test system to study
Biochem. Sci. 18, 471–475.nucleic acid-based antiviral approaches against HCV
Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M., and Rice, C. M.
gene expression in the cell. Several parameters concern- (1993). Expression and identification of hepatitis C virus polyprotein
ing antisense ODN (e.g., enhancement of cellular uptake cleavage products. J. Virol. 67, 1385–1395.
Harada, S., Watanabe, Y., Takeuchi, K., Suzuki, T., Katayama, T., Takebe,and development of nuclease-resistant ODN with fewer
Y., Saito, I., and Miyamura, T. (1991). Expression of processed corenonspecific inhibitory effects) need to be improved in
protein of hepatitis C virus in mammalian cells. J. Virol. 65, 3015–future studies.
3021.
In conclusion, the cell lines described here represent Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M., and Shimotohno,
important tools to study structural and functional proper- K. (1991). Gene mapping of the putative structural region of the hepa-
titis C virus genome by in vitro processing analysis. Proc. Natl. Acad.ties of the HCV core protein. Moreover, they may be
Sci. USA 88, 5547–5551.useful to evaluate gene therapeutic strategies aimed at
Kim, D. W., Suzuki, R., Harada, T., Saito, I., and Miyamura, T. (1994).inhibiting HCV gene expression and replication in the
Trans-suppression of gene expression by hepatitis C viral core pro-
cell. tein. Jpn. J. Med. Sci. Biol. 47, 211–220.
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